Aslan Dehghani | Manager of Nanoparticle Technologies
Sartorius Lab Instruments GmbH & Co. KG

Aslan Dehghani, Manager of Nanoparticle Technologies, Sartorius Lab Instruments GmbH & Co. KG

Biography: Aslan (Mehdi) Dehghani, Ph.D. Manager of Nanoparticle Technologies, Corporate Research, Sartorius Stedim North America Dr. Dehghani leads 3 groups in the Corporate Research Group of Sartorius; Nucleic Acid Delivery, Extracellular Vesicles and Miniaturization & Microfluidics. These projects are focused on fundamental studies around formulation, production, purification, and characterization by evaluating and developing new technologies and solutions for upstream and downstream processing as well as characterization. Before joining Sartorius Stedim North America in 2019, Aslan completed his Ph.D. degree from Rochester Institute of Technology focusing on purification, characterization, and therapeutic potential of EVs. He has published over 14 peer reviewed articles on EVs bioprocessing as well as an invited book chapter. Additionally, He has been an invited speaker to the world stem cell summit, the 1st and 2nd American exosome and RNA conferences, International Society of EVs, and Exosome Therapeutic Summit. He has been also honored the “Young Investigator of the Year Award” at the international society of EVs in 2020.

Appearances:



Day 2 (21st October) @ 14:30

Optimizing Downstream Processing for Next-Generation Vaccine Development - TBC

last published: 17/Sep/26 09:55 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2026

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com


Stan Dooley

Stan.Dooley@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay up-to-date

Join our mailing list to receive exclusive content and offers.